{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T09:47:06Z","timestamp":1793526426518,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T00:00:00Z","timestamp":1519084800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1208\/s12249-017-0945-4","type":"journal-article","created":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T17:07:16Z","timestamp":1519146436000},"page":"1454-1467","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Inhalable Levofloxacin Liposomes Complemented with Lysozyme for Treatment of Pulmonary Infection in Rats: Effective Antimicrobial and Antibiofilm Strategy"],"prefix":"10.1208","volume":"19","author":[{"given":"Purnima V.","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijit M.","family":"Nirwane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mangal S.","family":"Nagarsenker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,20]]},"reference":[{"issue":"178","key":"945_CR1","first-page":"1","volume":"4","author":"JL Lister","year":"2014","unstructured":"Lister JL, Horswill AR. Staphylococcus aureus biofilms: recent developments in biofilm dispersal. Front Cell Infect Microbiol. 2014;4(178):1\u20139.","journal-title":"Front Cell Infect Microbiol"},{"key":"945_CR2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.addr.2014.10.022","volume":"85","author":"QT Zhou","year":"2015","unstructured":"Zhou QT, Leung SSY, Tang P, Parumasivam T, Loh ZH, Chan HK. Inhaled formulations and pulmonary drug delivery systems for respiratory infections. Adv Drug Deliv Rev. 2015;85:83\u201399.","journal-title":"Adv Drug Deliv Rev"},{"issue":"5","key":"945_CR3","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.jcf.2015.02.005","volume":"14","author":"V Waters","year":"2015","unstructured":"Waters V, Smyth A. Cystic fibrosis microbiology: advances in antimicrobial therapy. J Cyst Fibros. 2015;14(5):551\u201360.","journal-title":"J Cyst Fibros"},{"issue":"25","key":"945_CR4","first-page":"5399","volume":"6","author":"AS Zakaria","year":"2012","unstructured":"Zakaria AS, Melake NA, Baky NA, El Rasheed NM, Ibrahim NH. In vitro and in vivo studies of antibacterial effect of ceftriaxone moxifloxacin combination against methicillin resistant Staphylococcus aureus biofilms formed on biomedical implants. Afr J Microbiol Res. 2012;6(25):5399\u2013409.","journal-title":"Afr J Microbiol Res"},{"key":"945_CR5","doi-asserted-by":"publisher","first-page":"445","DOI":"10.4161\/viru.2.5.17724","volume":"2","author":"N Archer","year":"2011","unstructured":"Archer N, Mazaitis M, Costerton J, Leid J, Powers M, Shirtliff M. Staphylococcus aureus biofilms: properties, regulation, and roles in human disease. Virulence. 2011;2:445\u201359.","journal-title":"Virulence"},{"issue":"1","key":"945_CR6","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1038\/emi.2015.1","volume":"4","author":"H Liu","year":"2015","unstructured":"Liu H, Zhao Y, Zhao D, Gong T, Wu Y, Han H, et al. Antibacterial and anti-biofilm activities of thiazolidione derivatives against clinical staphylococcus strains. Emerg Microbes Infect. 2015;4(1):e1. https:\/\/doi.org\/10.1038\/emi.2015.1 .","journal-title":"Emerg Microbes Infect"},{"key":"945_CR7","doi-asserted-by":"crossref","unstructured":"Estela CRL, Alejandro PR. Biofilms: a survival and resistance mechanism of microorganisms. In: Pana M, editors. Antibiotic resistant bacteria\u2014a continuous challenge in the new millennium. InTech; 2012. ISBN: 978\u2013953\u201351-0472-8.","DOI":"10.5772\/28504"},{"issue":"6","key":"945_CR8","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1097\/00002480-200011000-00037","volume":"46","author":"RM Donlan","year":"2000","unstructured":"Donlan RM. Role of biofilms in antimicrobial resistance. ASAIO J. 2000;46(6):S47\u201352.","journal-title":"ASAIO J"},{"issue":"2","key":"945_CR9","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/nrd1008","volume":"2","author":"D Davies","year":"2003","unstructured":"Davies D. Understanding biofilm resistance to antibacterial agents. Nat Rev Drug Discov. 2003;2(2):114\u201322.","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"945_CR10","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1021\/mp500846u","volume":"12","author":"J Du","year":"2015","unstructured":"Du J, Bandara H, Du P, Huang H, Hoang K, Nguyen D, et al. Improved biofilm antimicrobial activity of polyethylene glycol conjugated tobramycin compared to tobramycin in Pseudomonas aeruginosa biofilms. Mol Pharm. 2015;12(5):1544\u201353.","journal-title":"Mol Pharm"},{"issue":"4","key":"945_CR11","doi-asserted-by":"publisher","first-page":"784","DOI":"10.3390\/ijms18040784","volume":"18","author":"Y Hou","year":"2017","unstructured":"Hou Y, Wang Z, Zhang P, Bai H, Sun Y, Duan J, et al. Lysozyme associated liposomal gentamicin inhibits bacterial biofilm. Int J Mol Sci. 2017;18(4):784.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"945_CR12","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/nrd4000","volume":"12","author":"T Bjarnsholt","year":"2013","unstructured":"Bjarnsholt T, Ciofu O, Molin S, Givskov M, H\u00f8iby N. Applying insights from biofilm biology to drug development\u2014can a new approach be developed? Nat Rev Drug Discov. 2013;12(10):791\u2013808.","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"945_CR13","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.ejpb.2014.06.002","volume":"88","author":"A Martinelli","year":"2014","unstructured":"Martinelli A, Bakry A, D\u2019Ilario L, Francolini I, Piozzi A, Taresco V. Release behavior and antibiofilm activity of usnic acid-loaded carboxylated poly (l-lactide) microparticles. Eur J Pharm Biopharm. 2014;88(2):415\u201323.","journal-title":"Eur J Pharm Biopharm"},{"issue":"12","key":"945_CR14","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.1128\/AAC.00523-06","volume":"50","author":"O Murillo","year":"2006","unstructured":"Murillo O, Domenech A, Garcia A, Tubau F, Cabellos C, Gudiol F, et al. Efficacy of high doses of levofloxacin in experimental foreign-body infection by methicillin-susceptible Staphylococcus aureus. Antimicrob Agents Chemother. 2006;50(12):4011\u20137.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"945_CR15","first-page":"43","volume":"2","author":"J Penta","year":"2010","unstructured":"Penta J, Jannu KK, Musthyala R. Antimicrobial studies of selected antibiotics and their combination with enzymes. Int J Pharm Pharm Sci. 2010;2(3):43\u20134.","journal-title":"Int J Pharm Pharm Sci"},{"issue":"5","key":"945_CR16","first-page":"364","volume":"42","author":"MK Sakharkar","year":"2009","unstructured":"Sakharkar MK, Jayaraman P, Soe WM, Chow V, Sing LC, Sakharkar KR. In vitro combinations of antibiotics and phytochemicals against Pseudomonas aeruginosa. J Microbiol Immunol Infect. 2009;42(5):364\u201370.","journal-title":"J Microbiol Immunol Infect"},{"issue":"4","key":"945_CR17","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/j.1472-765X.2008.02548.x","volume":"48","author":"S Vuuren Van","year":"2009","unstructured":"Van Vuuren S, Suliman S, Viljoen A. The antimicrobial activity of four commercial essential oils in combination with conventional antimicrobials. Lett Appl Microbiol. 2009;48(4):440\u20136.","journal-title":"Lett Appl Microbiol"},{"issue":"1","key":"945_CR18","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1208\/s12249-012-9914-0","volume":"14","author":"M Venkataraman","year":"2013","unstructured":"Venkataraman M, Nagarsenker M. Silver sulfadiazine nanosystems for burn therapy. AAPS PharmSciTech. 2013;14(1):254\u201364.","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"945_CR19","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1093\/jac\/dkp158","volume":"64","author":"RO Darouiche","year":"2009","unstructured":"Darouiche RO, Mansouri MD, Gawande PV, Madhyastha S. Antimicrobial and antibiofilm efficacy of triclosan and DispersinB\u00ae combination. J Antimicrob Chemother. 2009;64(1):88\u201393.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"945_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4236\/ijaa.2012.21001","volume":"2","author":"DW Seifeldeen","year":"2012","unstructured":"Seifeldeen DW. Evaluation of the combination of N-acetylcysteine and or sodium salicylate with ciprofloxacin on bacterial adhesion and biofilm formation on urinary catheters. IAJAA. 2012;2(1):1\u201312.","journal-title":"IAJAA"},{"issue":"2","key":"945_CR21","first-page":"136","volume":"1","author":"X Gao","year":"2007","unstructured":"Gao X, Yao G, Guo N, An F, Guo X. A simple and rapid high performance liquid chromatography method to determine levofloxacin in human plasma and its use in a bioequivalence study. Drug Discover Ther. 2007;1(2):136\u201340.","journal-title":"Drug Discover Ther"},{"key":"945_CR22","first-page":"3","volume-title":"HPLC of peptides and proteins. vol. 251","author":"MI Aguilar","year":"2004","unstructured":"Aguilar MI. HPLC of peptides and proteins. vol. 251. New York: Springer; 2004. p. 3\u20138."},{"issue":"4","key":"945_CR23","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1211\/0022357011775668","volume":"53","author":"YH Liao","year":"2001","unstructured":"Liao YH, Brown MB, Martin GP. Turbidimetric and HPLC assays for the determination of formulated lysozyme activity. J Pharm Pharmacol. 2001;53(4):549\u201354.","journal-title":"J Pharm Pharmacol"},{"issue":"5","key":"945_CR24","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/10611860902795407","volume":"17","author":"X Zhang","year":"2009","unstructured":"Zhang X, Sun P, Bi R, Wang J, Zhang N, Huang G. Targeted delivery of levofloxacin-liposomes for the treatment of pulmonary inflammation. J Drug Target. 2009;17(5):399\u2013407.","journal-title":"J Drug Target"},{"issue":"1","key":"945_CR25","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ijpharm.2016.05.041","volume":"509","author":"P Pathak","year":"2016","unstructured":"Pathak P, Dhawan V, Magarkar A, Danne R, Govindarajan S, Ghosh S, et al. Design of cholesterol arabinogalactan anchored liposomes for asialoglycoprotein receptor mediated targeting to hepatocellular carcinoma: in silico modeling, in vitro and in vivo evaluation. Int J Pharm. 2016;509(1):149\u201358.","journal-title":"Int J Pharm"},{"key":"945_CR26","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1093\/jac\/dkp282","volume":"64","author":"DL MacLeod","year":"2009","unstructured":"MacLeod DL, Barker LM, Sutherland JL, Moss SC, Gurgel JL, Kenney TF, et al. Antibacterial activities of a fosfomycin\/tobramycin combination: a novel inhaled antibiotic for bronchiectasis. J Antimicrob Chemother. 2009;64:829\u201336.","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"945_CR27","doi-asserted-by":"publisher","first-page":"3776","DOI":"10.1128\/AAC.46.12.3776-3781.2002","volume":"46","author":"JF Marier","year":"2002","unstructured":"Marier JF, Lavigne J, Ducharme MP. Pharmacokinetics and efficacies of liposomal and conventional formulations of tobramycin after intratracheal administration in rats with pulmonary Burkholderia cepacia infection. Antimicrob Agents Chemother. 2002;46(12):3776\u201381.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"945_CR28","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1128\/AAC.38.5.1090","volume":"38","author":"A Omri","year":"1994","unstructured":"Omri A, Beaulac C, Bouhajib M, Montplaisir S, Sharkawi M, Lagace J. Pulmonary retention of free and liposome-encapsulated tobramycin after intratracheal administration in uninfected rats and rats infected with Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1994;38(5):1090\u20135.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"945_CR29","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method. Methods. 2001;25(4):402\u20138.","journal-title":"Methods"},{"issue":"3","key":"945_CR30","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1208\/s12249-009-9290-6","volume":"10","author":"SR Naikwade","year":"2009","unstructured":"Naikwade SR, Bajaj AN, Gurav P, Gatne MM, Soni PS. Development of budesonide microparticles using spray-drying technology for pulmonary administration: design, characterization, in vitro evaluation, and in vivo efficacy study. AAPS PharmSciTech. 2009;10(3):993\u20131012.","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"945_CR31","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ejpb.2012.09.002","volume":"83","author":"SH Lee","year":"2013","unstructured":"Lee SH, Teo J, Heng D, Ng WK, Chan HK, Tan RB. Synergistic combination dry powders for inhaled antimicrobial therapy: formulation, characterization and in vitro evaluation. Eur J Pharm Biopharm. 2013;83(2):275\u201384.","journal-title":"Eur J Pharm Biopharm"},{"issue":"4","key":"945_CR32","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1128\/AAC.21.4.531","volume":"21","author":"G Cisani","year":"1982","unstructured":"Cisani G, Varaldo PE, Grazi G, Soro O. High-level potentiation of lysostaphin anti-staphylococcal activity by lysozyme. Antimicrob Agents Chemother. 1982;21(4):531\u20135.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"945_CR33","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0168-1605(00)00330-5","volume":"60","author":"W Chung","year":"2000","unstructured":"Chung W, Hancock RE. Action of lysozyme and nisin mixtures against lactic acid bacteria. Int J Food Microbiol. 2000;60(1):25\u201332.","journal-title":"Int J Food Microbiol"},{"issue":"3","key":"945_CR34","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1365-2672.1992.tb01821.x","volume":"72","author":"A Pellegrini","year":"1992","unstructured":"Pellegrini A, Thomas U, Fellenberg RV, Wild P. Bactericidal activities of lysozyme and aprotinin against Gram-negative and Gram-positive bacteria related to their basic character. J Appl Bacteriol. 1992;72(3):180\u20137.","journal-title":"J Appl Bacteriol"},{"issue":"7","key":"945_CR35","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1128\/AAC.44.7.1818-1824.2000","volume":"44","author":"JN Anderl","year":"2000","unstructured":"Anderl JN, Franklin MJ, Stewart PS. Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Chemother. 2000;44(7):1818\u201324.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"945_CR36","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/BF01053992","volume":"131","author":"J Wecke","year":"1982","unstructured":"Wecke J, Lahav M, Ginsburg I, Giesbrecht P. Cell wall degradation ofStaphylococcus aureus by lysozyme. Arch Microbiol. 1982;131(2):116\u201323.","journal-title":"Arch Microbiol"},{"issue":"2","key":"945_CR37","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.archoralbio.2008.09.015","volume":"54","author":"Y Samaranayake","year":"2009","unstructured":"Samaranayake Y, Cheung B, Parahitiyawa N, Seneviratne C, Yau J, Yeung K, et al. Synergistic activity of lysozyme and antifungal agents against Candida albicans biofilms on denture acrylic surfaces. Arch Oral Biol. 2009;54(2):115\u201326.","journal-title":"Arch Oral Biol"},{"issue":"3","key":"945_CR38","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1513\/AnnalsATS.201311-395FR","volume":"11","author":"BS Quon","year":"2014","unstructured":"Quon BS, Goss CH, Ramsey BW. Inhaled antibiotics for lower airway infections. Ann Am Thorac Soc. 2014;11(3):425\u201334.","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"945_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pharmaceutics8010006","volume":"8","author":"D Cipolla","year":"2016","unstructured":"Cipolla D, Blanchard J, Gonda I. Development of liposomal ciprofloxacin to treat lung infections. Pharmaceutics. 2016;8(1):1\u201331.","journal-title":"Pharmaceutics"},{"issue":"8","key":"945_CR40","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.4155\/tde.13.71","volume":"4","author":"D Cipolla","year":"2013","unstructured":"Cipolla D, Gonda I, Chan H-K. Liposomal formulations for inhalation. Ther Deliv. 2013;4(8):1047\u201372.","journal-title":"Ther Deliv"},{"issue":"2","key":"945_CR41","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1086\/421997","volume":"39","author":"L Simon","year":"2004","unstructured":"Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004;39(2):206\u201317.","journal-title":"Clin Infect Dis"},{"key":"945_CR42","doi-asserted-by":"publisher","unstructured":"Feng X, Maze M, Koch LG, Britton SL, Hellman J. Exaggerated acute lung injury and impaired antibacterial defenses during Staphylococcus aureus infection in rats with the metabolic syndrome. PLoS One. 10(5):e0126906. https:\/\/doi.org\/10.1371\/journal.pone.0126906 .","DOI":"10.1371\/journal.pone.0126906"},{"issue":"9","key":"945_CR43","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1128\/IAI.65.9.3889-3895.1997","volume":"65","author":"L Yao","year":"1997","unstructured":"Yao L, Berman JW, Factor SM, Lowy FD. Correlation of histopathologic and bacteriologic changes with cytokine expression in an experimental murine model of bacteremic Staphylococcus aureus infection. Infect Immun. 1997;65(9):3889\u201395.","journal-title":"Infect Immun"},{"key":"945_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2009\/675753","volume":"2009","author":"H Summah","year":"2009","unstructured":"Summah H, Qu J-M. Biomarkers: a definite plus in pneumonia. Mediat Inflamm. 2009;2009:1\u20139.","journal-title":"Mediat Inflamm"},{"issue":"9","key":"945_CR45","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1182\/blood.V92.9.3007","volume":"92","author":"MB Hampton","year":"1998","unstructured":"Hampton MB, Kettle AJ, Winterbourn CC. Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood. 1998;92(9):3007\u201317.","journal-title":"Blood"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12249-017-0945-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-017-0945-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-017-0945-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T09:55:34Z","timestamp":1603878934000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12249-017-0945-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,20]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["945"],"URL":"https:\/\/doi.org\/10.1208\/s12249-017-0945-4","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,20]]},"assertion":[{"value":"7 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Protocol ofin vivostudy was approved by the Institution Animal Ethics Committee Bombay College of Pharmacy and carried out in accordance with the guidelines of Committee for the Purpose and Supervision of Animal Experiments.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}}]}}